Prognostic value of neutrophil-to-lymphocyte ratio change in patients with locally advanced non-small cell lung cancer treated with thoracic radiotherapy

被引:3
作者
Yin, Xiaoming [1 ]
Chen, Haijun [2 ]
Sun, Yunchuan [1 ]
Xiao, Li [1 ]
Lu, Hongling [1 ]
Guo, Wei [1 ]
Yang, Hongjuan [1 ]
Zhou, Jianxi [1 ]
Fan, Kui [1 ]
Liang, Wei [1 ]
机构
[1] Hebei Med Univ, Cangzhou Hosp Integrated Tradit Chinese & Western, Affiliated Hosp, Dept Radiat Oncol, 31 Huanghe West Rd, Cangzhou 061000, Hebei, Peoples R China
[2] Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou 061000, Hebei, Peoples R China
关键词
CONCURRENT CHEMORADIATION; RADIATION; SURVIVAL; CHEMORADIOTHERAPY; DURVALUMAB; THERAPY;
D O I
10.1038/s41598-024-62662-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In prior investigations, a correlation was established between patient outcomes in locally advanced non-small cell lung cancer (LA-NSCLC) following thoracic irradiation and parameters, such as pre/post-treatment neutrophil-to-lymphocyte ratio (NLR) and NLR change (Delta NLR). However, these parameters could potentially be influenced by radiation-related variables, such as gross tumor volume (GTV). The primary aim of this study was to elucidate the factors impacting post-treatment NLR and Delta NLR and to further assess their prognostic relevance. In this retrospective study, a cohort of 188 LA-NSCLC patients who underwent thoracic radiation between 2012 and 2017 was assessed. The calculation of pre/post-treatment NLR involved the use of absolute neutrophil and lymphocyte counts. Delta NLR was defined as the difference between post- and pre-treatment NLR values. To assess the relationships between various variables and overall survival (OS), local progression-free survival (LPFS), and distant metastasis-free survival (DMFS), the Kaplan-Meier technique and Cox proportional hazards regression were employed. Additionally, Spearman's rank correlation analysis was carried out to investigate correlations between the variables. The analysis revealed that both post-treatment NLR (r = 0.315, P < 0.001) and Delta NLR (r = 0.156, P = 0.032) were associated with GTV. However, OS, LPFS, and DMFS were not independently correlated with pre/post-treatment NLR. Delta NLR, on the other hand, exhibited independent associations with OS and DMFS (HR = 1.054, P = 0.020, and P = 0.046, respectively). Elevated Delta NLR values were linked to poorer OS (P = 0.023) and DMFS (P = 0.018) in the Kaplan-Meier analysis. Furthermore, when stratifying by GTV, a higher Delta NLR remained to be associated with worse OS and DMFS (P = 0.047 and P = 0.035, respectively) in the GTV <= 67.41 cm(3) group, and in the GTV > 67.41 cm(3) group (P = 0.028 and P = 0.042, respectively), highlighting Delta NLR as the sole independent predictive factor for survival and metastasis, irrespective of GTV.
引用
收藏
页数:9
相关论文
共 28 条
[1]   Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer [J].
Antonia, S. J. ;
Villegas, A. ;
Daniel, D. ;
Vicente, D. ;
Murakami, S. ;
Hui, R. ;
Yokoi, T. ;
Chiappori, A. ;
Lee, K. H. ;
de Wit, M. ;
Cho, B. C. ;
Bourhaba, M. ;
Quantin, X. ;
Tokito, T. ;
Mekhail, T. ;
Planchard, D. ;
Kim, Y. -C. ;
Karapetis, C. S. ;
Hiret, S. ;
Ostoros, G. ;
Kubota, K. ;
Gray, J. E. ;
Paz-Ares, L. ;
de Castro Carpeno, J. ;
Wadsworth, C. ;
Melillo, G. ;
Jiang, H. ;
Huang, Y. ;
Dennis, P. A. ;
Ozguroglu, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20) :1919-1929
[2]   Concurrent Daily Cisplatin and High-Dose Radiation Therapy in Patients With Stage III Non-Small Cell Lung Cancer [J].
Dieleman, Edith M. T. ;
Uitterhoeve, Apollonia L. J. ;
van Hoek, Meike W. ;
van Os, Rob M. ;
Wiersma, Jan ;
Koolen, Mia G. J. ;
Kolff, Merel Willemijn ;
Koning, Caro C. E. ;
Adam, Judit A. ;
Verberne, Hein J. ;
Annema, Jouke T. ;
Rasch, Coen R. N. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03) :543-551
[3]   Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial [J].
Faivre-Finn, Corinne ;
Vicente, David ;
Kurata, Takayasu ;
Planchard, David ;
Paz-Ares, Luis ;
Vansteenkiste, Johan F. ;
Spigel, David R. ;
Garassino, Marina C. ;
Reck, Martin ;
Senan, Suresh ;
Naidoo, Jarushka ;
Rimner, Andreas ;
Wu, Yi-Long ;
Gray, Jhanelle E. ;
Ozguroglu, Mustafa ;
Lee, Ki H. ;
Cho, Byoung C. ;
Kato, Terufumi ;
de Wit, Maike ;
Newton, Michael ;
Wang, Lu ;
Thiyagarajah, Piruntha ;
Antonia, Scott J. .
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (05) :860-867
[4]   Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC-Update from PACIFIC [J].
Gray, Jhanelle E. ;
Villegas, Augusto ;
Daniel, Davey ;
Vicente, David ;
Murakami, Shuji ;
Hui, Rina ;
Kurata, Takayasu ;
Chiappori, Alberto ;
Lee, Ki Hyeong ;
Cho, Byoung Chul ;
Planchard, David ;
Paz-Ares, Luis ;
Faivre-Finn, Corinne ;
Vansteenkiste, Johan F. ;
Spigel, David R. ;
Wadsworth, Catherine ;
Taboada, Maria ;
Dennis, Phillip A. ;
Ozguroglu, Mustafa ;
Antonia, Scott J. .
JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) :288-293
[5]   Prognostic value of delta inflammatory biomarker-based nomograms in patients with inoperable locally advanced NSCLC [J].
Guo, Meiying ;
Li, Wanlong ;
Li, Butuo ;
Zou, Bing ;
Wang, Shijiang ;
Meng, Xue ;
Sun, Xindong ;
Yu, Jinming ;
Wang, Linlin .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 72 :395-401
[6]   Radiation sensitivity of human and murine peripheral blood lymphocytes, stem and progenitor cells [J].
Heylmann, Daniel ;
Roedel, Franz ;
Kindler, Thomas ;
Kaina, Bernd .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1846 (01) :121-129
[7]   Interplay between inflammasomes and PD-1/PD-L1 and their implications in cancer immunotherapy [J].
Jiao, Zhongyu ;
Zhang, Jun .
CARCINOGENESIS, 2023, 44 (12) :795-808
[8]   Effect of Radiation Therapy on Composition of Lymphocyte Populations in Patients with Primary Breast Cancer [J].
Kobzeva, Irina ;
Astrelina, Tatiana ;
Suchkova, Yuliya ;
Malivanova, Tatyana ;
Usupzhanova, Daria ;
Brunchukov, Vitaliy ;
Rastorgueva, Anna ;
Nikitina, Victoria ;
Lubaeva, Ekaterina ;
Sukhova, Marina ;
Kirilchev, Alexey ;
Butkova, Tatyana ;
Izotov, Alexander ;
Malsagova, Kristina ;
Samoilov, Alexander ;
Pustovoyt, Vasiliy .
JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (09)
[9]   The prognostic value of volumetric changes of the primary tumor measured on Cone Beam -CT during radiotherapy for concurrent chemoradiation in NSCLC patients [J].
Kwint, Margriet ;
Stam, Barbara ;
Proust-Lima, Cecile ;
Philipps, Viviane ;
Hoekstra, Trynke ;
Aalbersberg, Else ;
Rossi, Maddalena ;
Sonke, Jan-Jakob ;
Belderbos, Jose ;
Walraven, Iris .
RADIOTHERAPY AND ONCOLOGY, 2020, 146 :44-51
[10]   The immunological and metabolic landscape in primary and metastatic liver cancer [J].
Li, Xin ;
Ramadori, Pierluigi ;
Pfister, Dominik ;
Seehawer, Marco ;
Zender, Lars ;
Heikenwalder, Mathias .
NATURE REVIEWS CANCER, 2021, 21 (09) :541-557